| Literature DB >> 27559431 |
Anis Chaari1, Karim Abdel Hakim1, Kamel Bousselmi1, Mahmoud Etman1, Mohamed El Bahr1, Ahmed El Saka1, Eman Hamza1, Mohamed Ismail1, Elsayed Mahmoud Khalil1, Vipin Kauts1, William Francis Casey1.
Abstract
Sepsis and septic shock are life threatening condition associated with high mortality rate in critically-ill patients. This high mortality is mainly related to the inadequacy between oxygen delivery and cellular demand leading to the onset of multiorgan dysfunction. Whether this multiorgan failure affect the pancreas is not fully investigated. In fact, pancreatic injury may occur because of ischemia, overwhelming inflammatory response, oxidative stress, cellular apoptosis and/or metabolic derangement. Increased serum amylase and/or lipase levels are common in patients with septic shock. However, imaging test rarely reveal significant pancreatic damage. Whether pancreatic dysfunction does affect the prognosis of patients with septic shock or not is still a matter of debate. In fact, only few studies with limited sample size assessed the clinical relevance of the pancreatic injury in this group of patients. In this review, we aimed to describe the epidemiology and the physiopathology of pancreatic injury in septic shock patients, to clarify whether it requires specific management and to assess its prognostic value. Our main finding is that pancreatic injury does not significantly affect the outcome in septic shock patients. Hence, increased serum pancreatic enzymes without clinical features of acute pancreatitis do not require further imaging investigations and specific therapeutic intervention.Entities:
Keywords: Amylase; Lipase; Pancreas; Prognosis; Septic shock
Year: 2016 PMID: 27559431 PMCID: PMC4942740 DOI: 10.4251/wjgo.v8.i7.526
Source DB: PubMed Journal: World J Gastrointest Oncol